CDEK
← All organizations

IRX Therapeutics

For profit

Also known as: IRX Therapeutics

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jul 1, 2005

Last known activity

Feb 9, 2017

Acquired by Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics on Nov 7, 2018

Timeline

1990s

  1. Jun 1, 1994

    IRX Therapeutics— Founded

2010s

  1. Nov 7, 2018

    Brooklyn Immunotherapeutics— Acquired By

  2. Nov 7, 2018

    Brooklyn Immunotherapeutics— Now

  3. Nov 17, 2018

    Brooklyn Immunotherapeutics— Acquired

Drugs by trial phase (10 distinct, 9 trials)

Indications

Studied for

Subsidiaries (1 direct, 37 total across the full acquisition tree)

Recent trials (3)

Details

Founded
New York, NY, US Jun 1, 1994
Last known activity
Feb 9, 2017